Floatz logo

[68ga]ga-nota-g5

Bile Duct Carcinoma

RenJi HospitalradiopharmaceuticalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

14 Active assets in the Bile Duct Carcinoma cohort.

Asset / SponsorPhaseRating
Capecitabine
University of Washington
Phase 1CC
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 1CC
Elimusertib
National Cancer Institute (NCI)
Phase 1CC
Ropidoxuridine
National Cancer Institute (NCI)
Phase 1CC
cgx1321
Curegenix Inc.
Phase 1CC

View all 16 →

Same molecule, other indications

[68ga]ga-nota-g5 is also rated in:

digestive system cancerDormant
D
Indicative ·
30 / 100
View asset →
digestive system neoplasmDormant
D
Indicative ·
30 / 100
View asset →
cancerDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →